Figure 6From: Antiangiogenic and Antitumoral Effects Mediated by a Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1)-Targeted DNAzymeIn vivo assessment of DT18 toxicity. (A) Effect of intravenously injected DT18 on body weight (n = 6). (B) Representative hematoxylin and eosin-stained sections of liver, lung, spleen and kidney from mice treated with DT18, INV-Ctrl or saline.Back to article page